Cochrane Abstracts
Sublingual immunotherapy for asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sublingual Immunotherapy for Asthma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439624/all/Sublingual_immunotherapy_for_asthma.
Sublingual immunotherapy for asthma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439624/all/Sublingual_immunotherapy_for_asthma. Accessed December 21, 2024.
Sublingual immunotherapy for asthma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439624/all/Sublingual_immunotherapy_for_asthma
Sublingual Immunotherapy for Asthma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439624/all/Sublingual_immunotherapy_for_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sublingual immunotherapy for asthma
ID - 439624
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439624/all/Sublingual_immunotherapy_for_asthma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
